SHANGHAI - Chinese drugmaker Sinovac Biotech has begun to administer a coronavirus vaccine to thousands of its staff as the race to secure an immunization for COVID-19 enters advanced clinical trials.
Some 3,000 employees and family members had been injected with the vaccine developed by the Nasdaq-listed company, according to the Sina Finance website and other reports quoting a Sinovac spokesperson on Sunday.
